[Corrigendum] Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells

Du,Jian; Tang,Bo; Wang,Jingwen; Sui,Hongtao; Jin,Xueli; Wang,Liming; Wang,Zhongyu

doi:10.3892/ijmm.2023.5303

November-2023 Volume 52 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

November-2023 Volume 52 Issue 5

Full Size Image

Correction Open Access

[Corrigendum] Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells

Authors:
- Jian Du
- Bo Tang
- Jingwen Wang
- Hongtao Sui
- Xueli Jin
- Liming Wang
- Zhongyu Wang
View Affiliations / Copyright

Affiliations: Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian 116011, P.R. China, Department of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian 116027, P.R. China, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden

Copyright: © Du et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 100
|
Published online on: September 4, 2023

https://doi.org/10.3892/ijmm.2023.5303
Expand metrics +

Article

Int J Mol Med 29: [Related article:] 607-612, 2012; DOI: 10.3892/ijmm.2012.884

Following the publication of the above article, an interested reader drew to the authors' attention that, for the western blots shown in Fig. 4 on p. 610, the two leftmost bands shown for the Bax data in Fig. 4A were strikingly similar to the two rightmost Mito Cyt C bands featured in Fig. 4C. The authors have checked their original data, and realized that these data were assembled incorrectly in this figure. The revised version of Fig. 4 is shown below, now featuring the correct Bax data in Fig. 4A. The authors confirm that the errors associated with this figure did not have any significant impact on either the results or the conclusions reported in this study, and are grateful to the Editor of International Journal of Molecular Medicine for allowing them the opportunity to publish this Corrigendum. Furthermore, they apologize to the readership of the Journal for any inconvenience caused.

Figure 4

The effect of alpinetin on the protein expression of Bcl-2 family members and XIAP and on the release of mitochondrial cytochrome c. BxPC-3 cells were treated with different concentrations (0, 20, 40, 60 and 80 μg/ml) of Alpinetin for 48 h. (A) The expression of Bcl-2, Bcl-xL, Bax and XIAP were determined by western blot analysis. (C) The expression of cytochrome c in mitochondria and cytoplasm were also examined by western blot analysis. (B and D) The western blot results were further analyzed using Gel-Pro Analyzer 4.0 software (*P<0.05). Results are representative of three independent experiments.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

[Corrigendum] Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells

This article is mentioned in:

Article

Figure 4

Related Articles